Project Details
Description
A Phase 2 Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of ARO-APOC3 in Adults With Dyslipidemia
| Status | Active |
|---|---|
| Effective start/end date | 6/21/22 → 6/21/27 |
Funding
- ARROWHEAD PHARMACEUTICALS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.